Peptide Therapy
in West Hollywood, CA
50+ physician-prescribed peptides curated like couture and delivered in a boutique Melrose Avenue setting under the medical direction of Dr. Ernst von Schwarz, MD, PhD.
Skin Regeneration & Aesthetic Peptides
Copper-binding tripeptides, pineal tetrapeptides, and melanocortin agonists that target the visible cues of skin quality — tone, texture, firmness, pigmentation, and post-procedure healing. The flagship category for Luxbae’s aesthetic clientele.
GHK-Cu
Copper-binding tripeptide studied for collagen synthesis, dermal fibroblast activation, and post-procedure repair. A foundation of Luxbae’s Glow Fusion protocol.
GHK-CuEpithalon
Telomerase-modulating peptide studied for sleep architecture, circadian rhythm, and longevity signaling. Frequently paired with aesthetic protocols for inside-out radiance.
EpithalonGHK / EpithalonBlend
Pairs collagen-stimulating copper signaling with telomere-focused longevity support. A signature stack for clients pursuing both surface radiance and cellular age markers.
GHK / Epithalon BlendGHK / Epi / MOTS-cBlend
Triple-action protocol combining skin regeneration, telomere maintenance, and mitochondrial energy. Designed for clients who want longevity to read on the face.
GHK / Epi / MOTS-c BlendMelanotan-2
Synthetic α-MSH analogue studied for melanogenesis (skin pigmentation) and centrally mediated libido response. Used selectively under physician guidance.
Melanotan-2Growth Hormone Secretagogues & Longevity Peptides
GHRH analogues, ghrelin agonists, and downstream IGF-1 signalers studied for body composition, sleep depth, recovery, and the markers of biological aging — restoring pulsatile GH rather than overriding it.
CJC-1295
Long-acting GHRH analogue studied for sustained elevation of baseline growth hormone and IGF-1. The backbone of most Luxbae longevity protocols.
CJC-1295CJC-1295 / IpamorelinBlend
The most widely prescribed growth hormone duo. CJC raises baseline GH while Ipamorelin triggers pulsatile release — a synergistic signaling pattern that mirrors youthful physiology.
CJC-1295 / Ipamorelin BlendIpamorelin
Selective ghrelin mimetic studied for pulsatile GH release with minimal effect on cortisol or prolactin — a cleaner profile than older secretagogues.
IpamorelinIPA / CJC / IGFBlend
Layers pulsatile GH release, sustained GH elevation, and direct IGF-1 signaling in one protocol — designed for the patient who wants every lever of the GH axis engaged.
IPA / CJC / IGF BlendIPA / SermorelinBlend
Sermorelin’s short half-life mirrors physiological GH pulses; Ipamorelin amplifies the signal. A gentler, well-tolerated stack for first-time GH patients.
IPA / Sermorelin BlendSermorelin
The first FDA-recognized GHRH analogue. Restores pulsatile growth hormone release with one of the longest clinical safety records in the category.
SermorelinTesamorelin
The GHRH analogue with the strongest clinical evidence for visceral adipose tissue reduction. FDA-approved for HIV-associated lipodystrophy and increasingly used off-label for body recomposition.
TesamorelinTesa / Ipa / MOTS-cBlend
Combines visceral fat reduction, pulsatile GH release, and mitochondrial energy signaling — engineered for clients pursuing both body composition and metabolic age.
Tesa / Ipa / MOTS-c BlendIGF-1 LR3
Extended half-life IGF-1 analogue studied for muscle protein synthesis, satellite cell activation, and cellular repair downstream of growth hormone signaling.
IGF-1 LR3IGF-LR3 / MOTS-cBlend
Pairs IGF-1’s anabolic muscle signaling with MOTS-c’s mitochondrial biogenesis — performance and metabolic flexibility in one protocol.
IGF-LR3 / MOTS-c BlendFOXO4-DRIComing Soon
Investigational senolytic peptide studied for selective clearance of senescent (zombie) cells — one of the most promising frontiers in cellular aging research.
FOXO4-DRIFollistatinComing Soon
Glycoprotein peptide studied for myostatin antagonism — releasing the natural brake on skeletal muscle growth. An advanced option for physique-focused clients.
FollistatinHealing Acceleration & Tissue Repair Peptides
BPC-157, Thymosin Beta-4, and synergistic blends studied for angiogenesis, tendon and ligament repair, gastrointestinal lining integrity, and post-procedure healing. Especially relevant alongside Morpheus8, CO2 resurfacing, PRP, and microneedling.
BPC-157
The most-cited healing peptide in preclinical literature. Studied for angiogenesis, tendon-to-bone healing, GI tract repair, and systemic anti-inflammatory effects.
BPC-157TB-500
Synthetic Thymosin Beta-4 analogue studied for actin sequestration, cell migration, and broad tissue regeneration — joints, skin, cardiac, and neurological.
TB-500BPC / TB-500 5mgBlend
The benchmark healing duo. BPC’s angiogenic and gut-lining effects plus TB-500’s systemic tissue repair — Luxbae’s most prescribed recovery protocol.
BPC / TB-500 5mg BlendBPC / TB-500 15mgBlend
A higher-dose iteration for post-surgical repair, chronic joint conditions, or athletes returning from significant tissue injury. Used selectively under MD supervision.
BPC / TB-500 15mg BlendTB / BPC / KPV / GHKQuad Blend
A four-peptide protocol layering tissue repair (BPC+TB), anti-inflammatory gut signaling (KPV), and skin/collagen regeneration (GHK-Cu) in a single formulation.
TB / BPC / KPV / GHK Quad BlendLL-37
Human cathelicidin-derived antimicrobial peptide studied for biofilm disruption, immune modulation, and wound healing in chronic infectious conditions.
LL-37BPC-157 OralOral
Encapsulated oral BPC formulated for direct gastrointestinal delivery. A preferred route for patients addressing gut-lining concerns or who prefer non-injectable options.
BPC-157 OralGLP-1 & Metabolic Optimization Peptides
From targeted lipolytic fragments to dual incretin receptor agonists, these compounds address appetite signaling, insulin sensitivity, gastric emptying, and energy expenditure — the molecular levers of sustained weight reduction.
AOD-9604
C-terminal HGH fragment studied for lipolytic activity and inhibition of lipogenesis without measurable effects on IGF-1 or blood glucose — a metabolic effect without GH downstream load.
AOD-9604Semaglutide S5
Low-dose GLP-1 protocol for patients beginning their weight management journey — gradual appetite reduction with the gentlest titration curve.
Semaglutide S5Semaglutide S10
Mid-dose GLP-1 tier for patients with established tolerance — meaningful appetite control and metabolic improvement at a sustainable cadence.
Semaglutide S10Semaglutide S20
High-dose GLP-1 protocol for patients requiring maximum appetite suppression after physiologic plateau. Reserved for advanced candidates under close monitoring.
Semaglutide S20Tirzepatide
Dual incretin receptor agonist with clinical evidence of superior weight reduction versus single-agonist GLP-1s. SURMOUNT-1 reported up to 22.5% mean body weight reduction at 72 weeks.
TirzepatideCagrilintideComing Soon
Long-acting amylin analogue studied for delayed gastric emptying and reduced caloric intake. Synergistic potential alongside GLP-1 agonists.
CagrilintideTesofensineComing Soon
Investigational monoamine reuptake inhibitor (serotonin, norepinephrine, dopamine) studied for appetite reduction and increased energy expenditure.
TesofensineNootropic & Neuroprotective Peptides
Peptides studied for their ability to cross the blood-brain barrier and modulate BDNF, GABAergic signaling, synaptogenesis, and sleep architecture — supporting cognitive performance without the side-effect profile of stimulant nootropics.
Dihexa
Angiotensin IV analogue studied in preclinical models for synaptogenesis and hepatocyte growth factor (HGF) signaling — one of the most potent BDNF-related compounds described in literature.
DihexaSemax
Russian-developed neuropeptide studied for BDNF and NGF upregulation, focus, memory consolidation, and stress resilience — without the dependence profile of stimulants.
SemaxSelank
Tuftsin analogue studied for modulation of GABAergic and serotonergic systems — anxiety attenuation and cognitive endurance without sedation.
SelankDSIP
Endogenous neuropeptide studied for normalization of delta-wave sleep, HPA axis modulation, and cortisol regulation — sleep architecture, not sedation.
DSIPDSIP / SelankBlend
Pairs DSIP for restorative deep sleep with Selank for daytime stress modulation — a quietly powerful duo for clients in high-pressure professional settings.
DSIP / Selank BlendSemax / Selank / DSIPBlend
Layers BDNF upregulation, anxiety relief, and deep-sleep restoration — built for the patient who wants daytime cognition and nighttime recovery in one signal.
Semax / Selank / DSIP Blend5-Amino-1MQOral
Oral nicotinamide N-methyltransferase inhibitor studied for adipocyte metabolism, intracellular NAD+ preservation, and mitochondrial efficiency.
5-Amino-1MQVitality & Hormonal Support Peptides
Centrally and peripherally acting peptides studied for libido, arousal, GnRH and gonadotropin signaling, and the relational neurochemistry of oxytocin — for both men and women, prescribed only after a thorough medical evaluation.
PT-141 (Bremelanotide)
Melanocortin receptor agonist with FDA-approved indication for hypoactive sexual desire disorder in premenopausal women, studied centrally rather than vascularly.
PT-141 (Bremelanotide)Kisspeptin
Upstream peptide that drives pulsatile GnRH release — the master regulator of the HPG axis and downstream LH, FSH, testosterone, and estrogen production.
KisspeptinGonadorelin
Synthetic GnRH analogue used alongside testosterone replacement therapy to maintain testicular volume, endogenous output, and fertility-preserving function.
GonadorelinOxytocin
The “pair-bond” neuropeptide studied for trust, intimacy, cortisol modulation, and orgasm intensity. Available compounded for sublingual or injectable delivery under MD direction.
OxytocinImmune Modulation & Cellular Energy Peptides
Thymic peptides, mitochondrial signalers, and anti-inflammatory compounds studied for T-cell regulation, innate immune balance, AMPK activation, and the cellular energy systems that decline measurably with age.
Thymosin Alpha-1
Thymic peptide studied for T-cell maturation, dendritic cell signaling, and innate immune modulation. Used internationally for immune dysfunction and chronic viral conditions.
Thymosin Alpha-1KPV
C-terminal α-MSH tripeptide studied for potent anti-inflammatory effects in the GI tract and systemically — particularly relevant in IBD, gut permeability, and inflammatory skin presentations.
KPVKPV / TA-1 / LL-37Blend
Layers gut anti-inflammatory signaling (KPV), T-cell modulation (Thymosin Alpha-1), and antimicrobial defense (LL-37) — a comprehensive immune stack.
KPV / TA-1 / LL-37 BlendMOTS-c
Mitochondria-derived peptide studied for AMPK activation, insulin sensitivity, and metabolic flexibility — one of the more compelling targets in mitochondrial biology.
MOTS-cNAD+
Essential dinucleotide cofactor central to energy metabolism, DNA repair (PARPs), and sirtuin activation. Declines measurably with age across human tissue.
NAD+KPV OralOral
Encapsulated KPV formulated for survival through gastric transit — delivers anti-inflammatory signaling to the GI tract and downstream immune system.
KPV OralSLU-PP-332Coming Soon
Investigational ERR (estrogen-related receptor) agonist studied as a small-molecule exercise mimetic — early data suggests cardiovascular and metabolic effects independent of physical activity.
SLU-PP-332How Peptide Therapy Works at Luxbae
Medical Consultation
A complimentary, no-pressure conversation with our medical team. We review your goals, current treatments, medications, and full medical history to confirm eligibility.
Targeted Lab Panel
Baseline labs covering the markers most relevant to your protocol — hormones, metabolic, inflammatory, and where appropriate, IGF-1 and full thyroid. Your protocol is built around your numbers.
Personalized Protocol
Dosing, cadence, and delivery method are tailored to you — no preset packages. Many clients pair peptides with Morpheus8, CO2, PRP, or facials, and your provider sequences them so each treatment reinforces the others.
Ongoing Refinement
Follow-up labs every 6–8 weeks. Dosing and stack adjust as your physiology responds. Continuous direct access to your medical team for questions, side effects, or recalibration.
Dr. Ernst von Schwarz, MD, PhD
Every peptide protocol at Luxbae is prescribed and supervised by Professor Dr. Ernst von Schwarz — a triple board-certified clinical and academic cardiologist, clinical professor of medicine at UCLA, and a three-decade pioneer in stem cell and regenerative medicine research. He has authored more than 150 peer-reviewed scientific papers and lectures internationally on cardiovascular and regenerative medicine. His clinical rigor is the reason Luxbae’s peptide program is built around labs, not lifestyle trends.
Meet Dr. von SchwarzPeptide Therapy FAQ
Common questions from clients at our West Hollywood location.
What is peptide therapy, and how does it actually work?
Are peptides FDA approved?
How is Luxbae different from online peptide companies?
Which peptides are most popular for weight loss in West Hollywood?
How soon do clients see results?
Can peptides be combined with Morpheus8, CO2, PRP, or facials?
Do you accept insurance? Are payment plans available?
Where is Luxbae located?
Clinical References
This page is reviewed by Dr. Ernst von Schwarz and the Luxbae medical team. The clinical statements on this page are supported by peer-reviewed research and FDA regulatory documentation. Individual results vary — consult with a qualified provider for personalized medical advice. These statements have not been evaluated by the FDA for any individual product not specifically approved by the agency.
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 2022.
- Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM, 2021.
- Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide. International Journal of Molecular Sciences, 2018.
- Sikiric P, Seiwerth S, Rucman R, et al. Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia/reperfusion. Inflammopharmacology, 2018.
- Goldstein AL, Hannappel E, Sosne G, Kleinman HK. Thymosin β4: a multi-functional regenerative peptide. Expert Opinion on Biological Therapy, 2012.
- Khorram O, Laughlin GA, Yen SS. Endocrine and Metabolic Effects of Long-term Administration of GHRH. JCEM, 1997.
- Kovalitskaya YA, Navolotskaya EV. Nonopioid effect of beta-endorphin and Selank. Biochemistry (Moscow), 2011.
- Falutz J, Allas S, Mamputu JC, et al. Long-term safety and effects of tesamorelin on visceral adipose tissue. JCEM, 2010.
- Kim KH, Son JM, Benayoun BA, Lee C. The Mitochondrial-Encoded Peptide MOTS-c Translocates to the Nucleus. Cell Metabolism, 2018.
- Khavinson V, Linkova N, Kozhevnikova E, Trofimova S. Epithalon Peptide and Its Effects on Aging and Telomere Biology. Biogerontology, 2020.
- Clayton AH, Althof SE, Kingsberg S, et al. Bremelanotide for female sexual dysfunctions in premenopausal women. Women’s Health, 2016.
Find Us on Melrose Avenue
Our boutique medical spa is located on Melrose Avenue in West Hollywood — convenient to Hollywood, Beverly Hills, Bel Air, Hancock Park, Studio City, and the greater Los Angeles area.
Sun 10 AM–4 PM
Build Your Protocol at Luxbae West Hollywood
Your consultation is complimentary. Our medical team will review your goals, walk you through which peptides are relevant to your case, and outline exactly which labs we’d run before starting. No pressure, no preset packages.